See LEGEND for key to shading and symbols.
Subject Area - OPTM Term - Term 3 2019
OPTM0001 | OPTM0002 | OPTM2133 | OPTM3201 | OPTM3233 | OPTM5211 |
OPTM5251 | OPTM6422 | OPTM6423 | OPTM6424 | OPTM7001 | OPTM7003 |
OPTM7117 | OPTM7208 | OPTM7218 | OPTM8514 | OPTM8522 | OPTM8523 |
Data is correct as at Mon 23 Sep 13:05:23 AEST 2019
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
OPTM0001 | Research Thesis Optometry F/T | ||||||
CRS | CR01 | 2890 | Open | 0/1 | 0% | (Course Enrolment, RSCH) | |
THE | 0001 | 3064 | Enr | Open | 39/40 | 98% | |
OPTM0002 | Research Thesis Optometry P/T | ||||||
CRS | CR01 | 2982 | Open | 0/7 | 0% | (Course Enrolment, RSCH) | |
THE | 0001 | 3065 | Enr | Open | 3/10 | 30% | |
OPTM2133 | The Clinical Environment | ||||||
CRS | CR01 | 2452 | Open | 0/28 | 0% | (Course Enrolment, UGRD) | |
LAB | GP1 | 8708 | Enr | Full | 24/24 | 100% | Tue 09-11 (w1-10, Myers 2009) |
LAB | GP2 | 8709 | Enr | Full | 24/24 | 100% | Wed 13-15 (w1-10, Myers 2009) |
LAB | GP3 | 8710 | Enr | Open | 12/24 | 50% | Thu 09-11 (w1-10, Myers 2009) |
LAB | GP4 | 8711 | Enr | Full | 24/24 | 100% | Thu 11-13 (w1-10, Myers 2009) |
LAB | GP5 | 8712 | Enr | Open | 22/24 | 92% | Thu 16-18 (w1-10, Myers 2009) |
LAB | GP6 | 8713 | Enr | Full | 24/24 | 100% | Fri 10-12 (w1-10, Myers 2009) |
LAB | GP7 | 8714 | Enr | Open | 22/24 | 92% | Fri 12-14 (w1-10, Myers 2009) |
LAB | GP8 | 8715 | Enr | Tent | 0/24 | 0% | Wed 09-11 (w1-10, Myers 2009) |
LEC | 001 | 8707 | Rel | Open | 152/180 | 84% | Mon 11 (w2-3,5-8,10, CLB 6); Mon 15 (w1-3,5-8,10, Webst ThA); Thu 14 (w1-10, ChemSc M18); Fri 09 (w1-7,10, ChemSc M18) |
TUT | A | 8716 | Rel | Full | 30/30 | 100% | Mon 12 (w1-3,5-10, Gold G02) |
TUT | B | 8717 | Rel | Stop | 29/30 | 97% | Mon 13 (w1-3,5-10, Gold G02) |
TUT | C | 8718 | Rel | Open | 28/30 | 93% | Mon 16 (w1-3,5-10, Gold G02) |
TUT | D | 8719 | Rel | Open | 12/30 | 40% | Mon 17 (w1-3,5-10, Gold G02) |
TUT | E | 8720 | Rel | Full | 30/30 | 100% | Tue 14 (w1-3,5-10, Gold G02) |
TUT | F | 8721 | Rel | Stop | 23/30 | 77% | Tue 15 (w1-3,5-10, Gold G02) |
OPTM3201 | Applied Vision Science | ||||||
CRS | CR01 | 2042 | Open | 0/8 | 0% | (Course Enrolment, UGRD) | |
LAB | GP1 | 8704 | Rel | Full | 24/24 | 100% | Tue 12-14 (w2-10, OPTM CL) |
LAB | GP2 | 8703 | Rel | Open | 22/24 | 92% | Thu 14-16 (w2-10, OPTM CL) |
LAB | GP3 | 8706 | Rel | Full | 24/24 | 100% | Wed 16-18 (w2-10, OPTM CL) |
LAB | GP4 | 8701 | Rel | Open | 18/22 | 82% | Thu 09-11 (w2-10, OPTM CL) |
LAB | GP5 | 8705 | Rel | Full | 22/22 | 100% | Wed 09-11 (w2-10, OPTM CL) |
LAB | GP6 | 8702 | Rel | Open | 20/22 | 91% | Thu 11-13 (w2-10, OPTM CL) |
LEC | A | 8700 | Enr | Open | 130/140 | 93% | Mon 12 (w1-3,5-11, ElecEngG23); Wed 13 (w1-10, ElecEngG23) |
OPTM3233 | Working in clinical contexts | ||||||
CRS | CR01 | 2141 | Open | 0/29 | 0% | (Course Enrolment, UGRD) | |
LAB | GP1 | 8722 | Enr | Open | 23/24 | 96% | Mon 13-15 (w1-3,5-9,11, Myers 2009); Mon 13-15 (w10, RMB 3051) |
LAB | GP2 | 8723 | Enr | Stop | 22/24 | 92% | Tue 14-16 (w1-9, Myers 2009); Tue 14-16 (w10, RMB 3051) |
LAB | GP3 | 8724 | Enr | Full | 24/24 | 100% | Tue 16-18 (w1-9, Myers 2009); Tue 16-18 (w10, RMB 3051) |
LAB | GP4 | 8725 | Enr | Open | 21/24 | 88% | Mon 15-17 (w1-3,5-9,11, Myers 2009); Mon 15-17 (w10, RMB 3051) |
LAB | GP5 | 8726 | Enr | Open | 21/24 | 88% | Wed 11-13 (w1-9, Myers 2009); Wed 11-13 (w10, RMB 3051) |
LAB | GP6 | 8727 | Enr | Tent | 0/24 | 0% | Thu 14-16 (w1-9, Myers 2009); Thu 14-16 (w10, RMB 3051) |
LEC | A | 8728 | Rel | Open | 111/140 | 79% | Mon 09 (w1-3,5-10,11, ElecEngG22); Mon 10 (w1-3,5-10,11, ElecEngG22) |
OPTM5211 | Clinical Optometry 5B | ||||||
CRS | CR01 | 3525 | Open | 0/0 | N/A | (Course Enrolment, UGRD) | |
OTH | 001 | 10009 | Enr | Full | 1/1 | 100% | |
OPTM5251 | Clinical Ocular Therap 5B | ||||||
CRS | CR01 | 10414 | Open | 0/0 | N/A | (Course Enrolment, UGRD) | |
OTH | 0001 | 10415 | Enr | Full | 1/1 | 100% | |
OPTM6422 | Clinical Optometry 4B | ||||||
CRS | CR01 | 1558 | Open | 0/7 | 0% | (Course Enrolment, PGRD) | |
LA1 | E | 8742 | Enr | Open | 22/24 | 92% | Tue 10 (w2-4, RMB 3050) |
LA1 | F | 8740 | Enr | Open | 18/24 | 75% | Tue 09 (w2-4, RMB 3050) |
LA1 | G | 8744 | Enr | Open | 22/24 | 92% | Tue 14 (w2-4, RMB 3050) |
LA1 | H | 8746 | Enr | Open | 17/24 | 71% | Tue 15 (w2-4, RMB 3050) |
LA2 | I | 8741 | Rel | Open | 18/24 | 75% | Tue 09 (w5-10, RMB 3050) |
LA2 | J | 8743 | Rel | Open | 21/24 | 88% | Tue 10 (w5-10, RMB 3050) |
LA2 | K | 8745 | Rel | Open | 18/24 | 75% | Tue 14 (w5-10, RMB 3050) |
LA2 | L | 8747 | Rel | Open | 22/24 | 92% | Tue 15 (w5-10, RMB 3050) |
LE1 | A | 8738 | Auto | Open | 79/86 | 92% | Mon 11 (w2-3,5-11, Myers Thtr) |
LE2 | M17A | 8739 | Rel | Open | 79/86 | 92% | Mon 17 (w2-10, OMB149) |
OPTM6423 | Posterior Eye Therapeutics | ||||||
CRS | CR01 | 1542 | Open | 0/22 | 0% | (Course Enrolment, PGRD) | |
LAB | GP1 | 8736 | Enr | Open | 20/24 | 83% | Tue 16-18 (w6-10, OPTM CL) |
LAB | GP2 | 8733 | Enr | Open | 14/24 | 58% | Thu 16-18 (w6-10, OPTM CL) |
LAB | GP3 | 8735 | Enr | Open | 19/24 | 79% | Tue 10-12 (w6-10, OPTM CL) |
LAB | GP4 | 8732 | Enr | Open | 21/24 | 88% | Fri 10-12 (w6-10, OPTM CL) |
LEC | A | 8731 | Auto | Open | 74/96 | 77% | Mon 08-11 (w8, Myers Thtr); Mon 09-11 (w2-3,5-7,9-11, Myers Thtr) |
OTH | M12A | 8734 | Rel | Open | 74/96 | 77% | Mon 12 (w6, ChemScM17) |
TUT | 501 | 8729 | Rel | Open | 74/84 | 88% | Fri 11-13 (w2-5, Mat 103) |
TUT | 502 | 8730 | Rel | Tent | 0/84 | 0% | Fri 09-11 (w2-5, Mat 103) |
OPTM6424 | Professional Optometry | ||||||
CRS | CR01 | 1007 | Open | 0/17 | 0% | (Course Enrolment, PGRD) | |
LEC | A | 8737 | Enr | Open | 79/96 | 82% | Mon 14-16 (w2-3,5-10, Myers Thtr); Thu 14-16 (w2-10, Myers Thtr) |
OPTM7001 | Intro to Community Eye Health | ||||||
CRS | CR01 | 1723 | Open | 0/0 | N/A | (Course Enrolment, PGRD) | |
OPTM7003 | Epid of Blinding Eye Diseases | ||||||
CRS | CR01 | 9977 | Open | 0/3 | 0% | (Course Enrolment, PGRD) | |
LEC | 001 | 3572 | Enr | Open | 5/8 | 63% | |
OPTM7117 | Ocular Therapy 2 | ||||||
CRS | CR01 | 1718 | Open | 0/2 | 0% | (Course Enrolment, PGRD) | |
LEC | 001 | 9985 | Enr | Open | 8/10 | 80% | |
OPTM7208 | Research Skills in Optometry | ||||||
CRS | CR01 | 1301 | Open | 0/29 | 0% | (Course Enrolment, PGRD) | |
LEC | 001 | 10386 | Enr | Open | 1/30 | 3% | |
OPTM7218 | Research Project | ||||||
CRS | CR01 | 3373 | Open | 0/27 | 0% | (Course Enrolment, PGRD) | |
LEC | 001 | 9986 | Enr | Open | 3/30 | 10% | |
OPTM8514 | Research Project | ||||||
CRS | CR01 | 1273 | Open | 0/5 | 0% | (Course Enrolment, PGRD) | |
OTH | 004 | 10008 | Enr | Open | 79/84 | 94% | |
OPTM8522 | Clinical Optometry 5B | ||||||
CRS | CR01 | 1550 | Open | 0/2 | 0% | (Course Enrolment, PGRD) | |
LE1 | A | 8748 | Enr | Open | 73/130 | 56% | Mon 17 (w1, OMB149); Mon 17 (w2-3,5-8,11, See School) |
LE2 | F13A | 8749 | Rel | Open | 73/75 | 97% | Fri 13 (w1-8, Myers 2030) |
OPTM8523 | Clinical Ocular Therapy 5B | ||||||
CRS | CR01 | 1500 | Open | 0/2 | 0% | (Course Enrolment, PGRD) | |
CLN | 001 | 10007 | Enr | Open | 73/75 | 97% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |